Identification of O-GlcNAc sites within peptides of the Tau protein and their impact on phosphorylation
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Phosphorylation of the microtubule-associated Tau protein plays a major role in the regulation of its activity of tubulin polymerization and/or stabilization of microtubuleassembly. A dysregulation of the phosphorylation/dephosphorylation balance leading to the hyperphosphorylation of Tau proteins in neurons is thought to favor their aggregation into insoluble filaments. This in turn might underlie neuronal death as encountered in many neurodegenerative disorders, including Alzheimer's disease. Another post-translational modification, the O-linked β-N-acetylglucosaminylation (O-GlcNAcylation), controls the phosphorylation state of Tau, although the precise mechanism is not known. Moreover, analytical difficulties have hampered the precise localization of the O-GlcNAc sites on Tau, except for the S400 site that was very recently identified on the basis of ETD-FT-MS. Here, we identify three O-GlcNAc sites by screening a library of small peptides sampling the proline-rich, the microtubule-associated repeats and the carboxy-terminal domains of Tau as potential substrates for the O-β-N-acetylglucosaminyltransferase (OGT). The in vitro activity of the nucleocytoplasmic OGT was assessed by tandem mass spectrometry and NMR spectroscopy. Using phosphorylated peptides, we establish the relationship between phosphate and O-GlcNAc incorporation at these sites. Phosphorylation of neighboring residues S396 and S404 was found to decrease significantly S400 O-GlcNAcylation. Reciprocally, S400 O-GlcNAcylation reduces S404phosphorylation by the CDK2/cyclinA3kinase and interrupts the GSK3β-mediated sequential phosphorylation process.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cycling of O-linked β-N-acetylglucosamine on nucleocytoplasmic proteins
Hart, G. W., Housley, M. P., & Slawson, C. (2007) · Nature · doi:10.1038/nature05815 · Cited by 1,418
O-GlcNAcylation regulates phosphorylation of tau: A mechanism involved in Alzheimer's disease
Liu, F., Iqbal, K., Grundke-Iqbal, I., Hart, G. W., & Gong, C.-X. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400348101 · Cited by 775
Hanger, D. P., Hughes, K., Woodgett, J. R., Brion, J.-P., & Anderton, B. H. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90774-2 · Cited by 737
A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo
Yuzwa, S. A., Macauley, M. S., Heinonen, J. E., Shan, X., Dennis, R. J., He, Y., Whitworth, G. E., Stubbs, K. A., McEachern, E. J., Davies, G. J., et al. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.96 · Cited by 717
Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205
Goedert, M., Jakes, R., & Vanmechelen, E. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11484-e · Cited by 608
Proline-directed and non-proline-directed phosphorylation of PHF-tau
Morishima-Kawashima, M., Hasegawa, M., Takio, K., Suzuki, M., Yoshida, H., Titani, K., & Ihara, Y. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.2.823 · Cited by 557
Liu, F., Shi, J., Tanimukai, H., Gu, J., Gu, J., Grundke-Iqbal, I., Iqbal, K., & Gong, C.-X. (2009) · Brain · doi:10.1093/brain/awp099 · Cited by 439
PP2A holoenzyme assembly: In cauda venenum (the sting is in the tail)
Janssens, V., Longin, S., & Goris, J. (2008) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2007.12.004 · Cited by 390
Goedert, M., Jakes, R., Crowther, R. A., Cohen, P., Vanmechelen, E., Vandermeeren, M., & Cras, P. (1994) · Biochemical Journal · doi:10.1042/bj3010871 · Cited by 375
The Microtubule-associated Protein Tau Is Extensively Modified with O-linked N-acetylglucosamine
Arnold, C. S., Johnson, G. W., Cole, R. N., Dong, D. L.-Y., Lee, M., & Hart, G. W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.28741 · Cited by 361
Research works printed but not linked: 58
- Hart, 2007, Nature, 446, 1017
- Liu, 2009, Brain, 132, 1820
- Yuzwa, 2008, Nat. Chem. Biol., 4, 483
- Lefebvre, 2003, Biochim. Biophys. Acta, 1619, 167
- Liu, 2004, Proc. Natl. Acad. Sci. U. S. A., 101, 10804
- Fischer, 2008, Nat. Chem. Biol., 4, 448
- Gong, 2006, J. Alzheimer's Dis., 9, 1
- Liu, 2008, FEBS Lett., 582, 359
- Robertson, 2004, J. Alzheimer's Dis., 6, 489
- Martinez-Fleites, 2010, Biochim. Biophys. Acta, 1800, 122
- Gao, 2001, J. Biol. Chem., 276, 9838
- Hanover, 2003, Arch. Biochem. Biophys., 409, 287
- Jinek, 2004, Nat. Struct. Mol. Biol., 11, 1001
- Clarke, 2008, EMBO J., 27, 2780
- Martinez-Fleites, 2008, Nat. Struct. Mol. Biol., 15, 764
- Arnold, 1996, J. Biol. Chem., 271, 28741
- Wang, 2010, Mol. Cell. Proteomics, 9, 153
- Yuzwa, 2010, Amino Acids
- Amniai, 2009, FASEB J., 23, 1146
- Landrieu, 2006, J. Am. Chem. Soc., 128, 3575
- Landrieu, 2010, Biochem. Soc. Trans., 38, 1006
- Leroy, 2010, J. Biol. Chem., 285, 33435
- Kosik, 2005, Biochim. Biophys. Acta, 1739, 298
- Morishima-Kawashima, 1995, J. Biol. Chem., 270, 823
- Morishima-Kawashima, 1995, Neurobiol. Aging, 16, 365
- Sergeant, 2005, Biochim. Biophys. Acta, 1739, 179
- Stoothoff, 2005, Biochim. Biophys. Acta, 1739, 280
- Dehennaut, 2008, Biochem. Biophys. Res. Commun., 369, 539
- Drewes, 1993, FEBS Lett., 336, 425
- Goedert, 1995, J. Neurochem., 65, 2804
- Gong, 1994, Neuroscience, 61, 765
- Xu, 2008, Mol. Cell, 31, 873
- Janssens, 2001, Biochem. J., 353, 417
- Janssens, 2008, Trends Biochem. Sci., 33, 113
- Virshup, 2009, Mol. Cell, 33, 537
- Cheung, 2008, J. Biol. Chem., 283, 33935
- Daly, 2000, Biochemistry, 39, 9039
- Goux, 2004, J. Biol. Chem., 279, 26868
- Rojas Quijano, 2006, Biochemistry, 45, 4638
- Smet, 2005, FEBS Lett., 579, 4159
- Smet, 2004, ChemBioChem, 5, 1639
- Goedert, 1994, Biochem. J., 301, 871
- Goedert, 1995, Neurosci. Lett., 189, 167
- Spillantini, 1996, Acta Neuropathol., 92, 42
- Brownlees, 1997, NeuroReport, 8, 3251
- Hanger, 1992, Neurosci. Lett., 147, 58
- Lovestone, 1994, et al., Curr. Biol., 4, 1077
- Lucas, 2001, EMBO J., 20, 27
- Spittaels, 2000, J. Biol. Chem., 275, 41340
- Li, 2006, Biochemistry, 45, 3125
- Li, 2006, Biochemistry, 45, 3134
- Gross, 2005, J. Am. Chem. Soc., 127, 14588
- Brown, 1999, Nat. Cell Biol., 1, 438
- Welburn, 2005, Methods Mol. Biol. (Clifton, N.J.), 296, 219
- Leymarie, 2002, Anal. Chem., 74, 4124
- Khidekel, 2007, Nat. Chem. Biol., 3, 339
- Rexach, 2008, Nat. Chem. Biol., 4, 97
- Hackenberger, 2008, Angew. Chem., Int. Ed., 47, 10030
Cited by
Roles of tau protein in health and disease
Guo, T., Noble, W., & Hanger, D. P. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1707-9 · Cited by 1,003
Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation
Yuzwa, S. A., Shan, X., Macauley, M. S., Clark, T., Skorobogatko, Y., Vosseller, K., & Vocadlo, D. J. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.797 · Cited by 611
Wang, J.-Z., Xia, Y.-Y., Grundke-Iqbal, I., & Iqbal, K. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-129031 · Cited by 532
Tau Protein Modifications and Interactions: Their Role in Function and Dysfunction
Mietelska-Porowska, A., Wasik, U., Goras, M., Filipek, A., & Niewiadomska, G. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15034671 · Cited by 404
Alquezar, C., Arya, S., & Kao, A. W. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2020.595532 · Cited by 367
Role of O-linked N-acetylglucosamine protein modification in cellular (patho)physiology
Chatham, J. C., Zhang, J., & Wende, A. R. (2021) · Physiological Reviews · doi:10.1152/physrev.00043.2019 · Cited by 352
Nutrient regulation of signaling and transcription
Hart, G. W. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.aw119.003226 · Cited by 345
The role of protein glycosylation in Alzheimer disease
Schedin‐Weiss, S., Winblad, B., & Tjernberg, L. O. (2014) · The FEBS Journal · doi:10.1111/febs.12590 · Cited by 317
Alzheimer's disease and type 2 diabetes: a critical assessment of the shared pathological traits
Chatterjee, S., & Mudher, A. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00383 · Cited by 270
“In vitro studies in NMR and Mass spectrometry analysis by Smet-Nocca et al. demonstrated that tau hyper phosphorylation at residues Ser-396 and Ser-404 were reduced by O-glycosylation at Ser400 (Smet-Nocca et al., 2011).”
BackgroundThe Emerging Link between O-GlcNAc and Alzheimer Disease
Zhu, Y., Shan, X., Yuzwa, S. A., & Vocadlo, D. J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.r114.601351 · Cited by 267
Protein phosphorylation in neurodegeneration: friend or foe?
Tenreiro, S., Eckermann, K., & Outeiro, T. F. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00042 · Cited by 252
Yuzwa, S. A., & Vocadlo, D. J. (2014) · Chem. Soc. Rev. · doi:10.1039/c4cs00038b · Cited by 247
Network Medicine in Pathobiology
Lee, L. Y.-H., & Loscalzo, J. (2019) · The American Journal of Pathology · doi:10.1016/j.ajpath.2019.03.009 · Cited by 95
Russell, C. L., Mitra, V., Hansson, K., Blennow, K., Gobom, J., Zetterberg, H., Hiltunen, M., Ward, M., & Pike, I. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-160633 · Cited by 52
Metadata
- Authors
- Smet-Nocca, C., Broncel, M., Wieruszeski, J.-M., Tokarski, C., Hanoulle, X., Leroy, A., Landrieu, I., Rolando, C., Lippens, G., & Hackenberger, C. P. R.
- Venue
- Molecular BioSystems
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-02-16
- Volume
- 7
- Issue
- 5
- Pages
- 1420-1429
- ISSN
- 1742-2051 (ISSN-L)
- 1742-206X
- OpenAlex
- W1974906557
- Cited by
- 132
- References
- 13
- FWCI
- 4.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.